Equity Analysis /
United States of America

US : NGM Biopharmaceuticals, Inc. - NGM | Downgrade to Outperform; Ripping Off the NASH Band-Aid

    Contributors
    Timur Ivannikov
    Ryan Deschner
    CGS-CIMB
    25 May 2021
    Published by